v3.25.0.1
Consolidated Statements of Earnings - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net revenues (Notes 6 & 13) [1],[2] $ 37,878 $ 35,174 $ 31,762
Cost of sales (Notes 4 & 5) 13,329 12,893 11,402
Gross profit 24,549 22,281 20,360
Marketing, administration and research costs (Notes 3, 4, 5, 13 & 20) 11,147 10,060 8,114
Impairment of goodwill (Note 5) 0 665 0
Operating income 13,402 11,556 12,246
Interest expense, net (Note 15) 1,143 1,061 588
Pension and other employee benefit costs (Note 14) 60 45 24
Earnings before income taxes 12,199 10,450 11,634
Provision for income taxes (Note 12) 3,017 2,339 2,244
Impairment related to the RBH equity investment (Note 6) 2,316 0 0
Equity investments and securities (income)/loss, net (637) (157) (137)
Net earnings 7,503 8,268 9,527
Net earnings attributable to noncontrolling interests 446 455 479
Net earnings attributable to PMI $ 7,057 $ 7,813 $ 9,048
Per share data (Note 11):      
Basic earnings per share (in dollars per share) $ 4.53 $ 5.02 $ 5.82
Diluted earnings per share (in dollars per share) $ 4.52 $ 5.02 $ 5.81
[1] Includes net revenues from related parties of $3,876 million, $3,553 million and $3,658 million for the years ended December 31, 2024, 2023 and 2022, respectively
[2] Net revenues are shown net of excise tax on products. For the years ended December 31, 2024, 2023 and 2022, excise tax on products was $51,563 million, $49,404 million and $48,958 million, respectively